miR-625-3p regulates oxaliplatin resistance by targeting MAP2K6-p38 signalling in human colorectal adenocarcinoma cells.

Nat Commun · 2016 · PMC4990699 · PMID 27526785

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

borderline significantno p-value reported

A small decrease in cell death was also observed for 2 and 8 μM oxPt in miR-625-3p overexpressing SW620.625 cells although this was only borderline significant ( Fig. 2a ).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.